Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by LMH STRATEGIC SOLUTIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2026
Income
$30,000.00
Expenses
Not reported
Filing UUID
09f4780a-8abc-4289-a0cf-09291ef258a8
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Pharmaceutical Supply Chain. H.R.2213: Medical Supply Chain Resiliency Act. Issues related to the 340(b) program. H.R.1492/S.832: EPIC Act of 2025.

Literal federal measure citations: H.R.2213, H.R.1492, S.832

TRD · Trade (domestic/foreign)

Issues related to USTR/trade.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.